Evaluating the Cost Effectiveness of STEADI
STEADI
1 other identifier
interventional
780
1 country
1
Brief Summary
Stopping Elderly Accidents, Deaths, and Injuries (STEADI) is an intervention to prevent falls among older adults developed by the Centers for Disease Control \& Prevention (CDC). Studies piloting the intervention have shown promising results; however, more evidence is needed to show that the intervention can be implemented cost-effectively on a larger scale in a real-world integrated health system. To this end, NORC partnered with Emory University School of Medicine to evaluate the effectiveness and cost-effectiveness of the STEADI intervention. This study aims to answer the following research questions to fill remaining knowledge gaps about STEADI:
- 1.Does STEADI significantly reduce falls among the target population compared to the standard of care?
- 2.Does partial implementation of some selected STEADI modules, also significantly reduce falls among the target population as compared to the standard of care?
- 3.Does the net present value of falls and resulting injuries averted by STEADI implementation exceed the net present value of the costs of STEADI implementation and the incremental costs that result from it?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2022
CompletedFirst Submitted
Initial submission to the registry
May 5, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2023
CompletedNovember 9, 2023
November 1, 2023
1.5 years
May 5, 2022
November 8, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Falls recorded in the Electronic Medical Record.
Falls identified in Emory Electronic Health Record as determined by the presence of ICD-10 diagnosis codes (W00-W19).
Within one year after patient completes STEADI assessment.
Medically treated falls reported in patient surveys
Self-reports of falls that were treated in a medical setting (regardless of whether it was treated at a study affiliated site)
Within one year after patient completes STEADI assessment
Non-medically treated falls reported in patient surveys
Self-reports of falls that were not treated in a medical setting,
Within one year after patient completes STEADI assessment
Total cost of all medical services
Cumulative health care allowable charges (or payments if available from claims data) for all patient services as observed in electronic health records, the estimated costs of services rendered outside of Emory Healthcare, the per person cost of screening and assessment, and the per person cost of STEADI-based fall prevention implementation.
Within one year after patient completes STEADI assessment
Secondary Outcomes (12)
Use of primary care medical services
Within one year after STEADI assessment
Use of physical therapy medical services
Within one year after STEADI assessment
Use of occupational therapy medical services
Within one year after STEADI assessment
Use of eye care services
Within one year after STEADI assessment
Use of podiatry services
Within one year after STEADI assessment
- +7 more secondary outcomes
Study Arms (4)
STEADI Intervention
EXPERIMENTALFor those assigned to the STEADI intervention arm, the clinical research nurse conducted standardized assessments to identify a patient's risk factors for falls. The STEADI assessments included: 1) a review of comorbidities; 2) medication review; 3) review of patient's falls history; 4) assessment of feet and footwear; 5) assessment of visual acuity; and 6) assessment of gait and balance; 7) review of home safety risks; and 8) assessment of potential vitamin D deficiency. Nurses would use assessment results to make recommendations which would then be relayed to the patient through their provider at their upcoming primary care visit.
Control
NO INTERVENTIONAfter being enrolled in the study, the patient would receive usual care from their provider.
Physical Therapy Assessment Only
EXPERIMENTALFor those assigned to the PT assessment only arm, the clinical research nurse would only conduct gait and balance assessments and would make recommendations about need for physical therapy services, conveyed to primary care provider for referrals.
Medical management assessment only
EXPERIMENTALFor those assign to the medical management assessment arm, only patients' medication usage would be assessed for polypharmacy (using 5 or more medications) or use of pharmaceutical classes that increase risk for falls. Recommendations for making changes to dosing levels or reducing number of medications would be conveyed to primary care provider.
Interventions
Patients are given Time Up and Go (TUG) tests, 30-second chair test, and 4-stage balance test (side-by-side, instep, tandem, and one foot).
Patients' medication history in the EHR is assessed for polypharmacy (using 5 or more medications concurrently) and use of medication in the following classes: tricyclic antidepressants, antihistamines, antiemetics, antipsychotics, antispasmotics, muscle relaxants, benzodiazepines, hypnotics, and opioids. The CRN confirms prescriptions with the patient. The CRN reports the medication risk in her provider report and provides medication management educational materials to the patient. At the patient's upcoming primary care visit, providers evaluated whether the medications associated with increased fall risk could be adjusted.
The clinical research nurse reviews the patient's EHR problem list for diagnoses of comorbidities associated with increased fall risk including: cognition problems, Parkinson's disease, cardiac issues, depression, or incontinence. Comorbidities are shared with providers in the recommendation statement.
The CRN asks how many times the patient had fallen in the past 12 months, whether those with falls sought medical attention, and if they experienced blackouts, loss of consciousness, or a broken/fractured bone(s) resulting from a fall. Fall history information is added to the provider report to increase the salience of fall prevention information.
The CRN observes or asks about the patient's current footwear, asks about foot pain or loss of sensation, and notes a diabetes diagnosis when applicable. Patient reports of foot pain, loss of sensation or diabetes result in a CRN note to the provider to examine the patient's feet and the potential need for a referral to podiatry. The CRN also reviewed a safe footwear handout with all patients regardless of their responses and emailed it to patients with other patient information following the call.
The CRN projects a Banner eye chart on Zoom for the patient to read with their contacts or glasses from five feet away for both eyes together and each eye individually. Phone patients are asked to self-report any vision problems. If either the video screening or patient self-report indicated any vision problems, the CRN notes the result and recommendation for eye care referral for the patient's provider to review and order.
The CRN reviews the CDC brochure "Check for Safety: A Home Fall Prevention Checklist for Older Adults" with each patient. Check for Safety asks 17 questions about the home's floors, stairs and steps, kitchen, bathrooms, and bedrooms and suggests ideas for removing or reducing fall hazards. The CRN communicates home safety risks and a recommendation for occupational therapy to the provider for indicated patients.
The CRN asks the patient if they usually take a Vitamin D supplement with their other medications. If the patient does not take a Vitamin D supplement, the CRN recommends the provider check Vitamin D levels and consider supplementation if Vitamin D levels are less than 20 ng/mL.
Eligibility Criteria
You may qualify if:
- With a non-acute outpatient visit scheduled at one of the five participating primary care clinics during the study period
- Stay Independent Screening (SIS) score of 4 or higher or an answer of "yes" to one of following three key questions in the SIS:
- "Have you fallen in the past year?"
- "Do you feel unsteady when standing or walking?"
- "Do you worry about falling?"
- English proficient
- Access to an able-bodied person to help with gait and balance assessments
You may not qualify if:
- Evidence in medical record of severe cognitive deficiencies (such as advanced Alzheimer's or dementia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Opinion Research Centerlead
- Emory Healthcarecollaborator
- Centers for Disease Control and Preventioncollaborator
Study Sites (1)
Emory Healthcare
Atlanta, Georgia, 30033, United States
Related Publications (1)
Rein DB, Hackney ME, Haddad YK, Sublett FA, Moreland B, Imhof L, Peterson C, Legha JK, Mark J, Vaughan CP, Johnson Ii TM, Bergen G; Emory STEADI Implementation team. Telemedicine-Based Risk Program to Prevent Falls Among Older Adults: Protocol for a Randomized Quality Improvement Trial. JMIR Res Protoc. 2024 Mar 26;13:e54395. doi: 10.2196/54395.
PMID: 38346180DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Rein, PhD
National Opinion Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Program Area Director
Study Record Dates
First Submitted
May 5, 2022
First Posted
May 25, 2022
Study Start
July 29, 2020
Primary Completion
January 15, 2022
Study Completion
September 18, 2023
Last Updated
November 9, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
IPD will not be available to other researchers.